Table 7 KEEG pathways enriched by mRNAs
Pathway ID | Description | P-value | Count |
|---|---|---|---|
hsa04970 | Salivary secretion | 1.38E−06 | 14 |
hsa05204 | Chemical carcinogenesis | 2.65E−06 | 13 |
hsa00982 | Drug metabolism—cytochrome P450 | 2.77E−06 | 12 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.08E−06 | 12 |
hsa04972 | Pancreatic secretion | 1.58E−05 | 13 |
hsa04918 | Thyroid hormone synthesis | 0.000156 | 10 |
hsa04971 | Gastric acid secretion | 0.000175 | 10 |
hsa00053 | Ascorbate and aldarate metabolism | 0.000213 | 6 |
hsa04610 | Complement and coagulation cascades | 0.00027 | 10 |
hsa04924 | Renin secretion | 0.000276 | 9 |
hsa00830 | Retinol metabolism | 0.000311 | 9 |
hsa00140 | Steroid hormone biosynthesis | 0.000696 | 8 |
hsa00040 | Pentose and glucuronate interconversions | 0.000795 | 6 |
hsa00590 | Arachidonic acid metabolism | 0.000974 | 8 |
hsa00983 | Drug metabolism—other enzymes | 0.001185 | 9 |
hsa04979 | Cholesterol metabolism | 0.001238 | 7 |
hsa04966 | Collecting duct acid secretion | 0.001754 | 5 |
hsa04923 | Regulation of lipolysis in adipocytes | 0.00196 | 7 |
hsa04974 | Protein digestion and absorption | 0.002961 | 9 |